Prestige Consumer Healthcare Inc. (PBH)

Revenue Breakdown

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Revenue	913.58M	960.01M
North American OTC Healthcare Revenue Growth	-4.84%	0.18%
International OTC Healthcare Revenue	175.13M	177.75M
International OTC Healthcare Revenue Growth	-1.48%	6.38%
Revenue (Other)	5.00K	-2.00K
Revenue (Total)	1.09B	1.14B
Revenue (Total) Growth	-4.31%	1.10%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Analgesics Revenue	113.94M	117.70M
Analgesics Revenue Growth	-3.19%	0.21%
Cough & Cold Revenue	101.91M	106.21M
Cough & Cold Revenue Growth	-4.05%	-10.76%
Women's Health Revenue	227.77M	236.83M
Women's Health Revenue Growth	-3.83%	-1.49%
Gastrointestinal Revenue	259.79M	255.94M
Gastrointestinal Revenue Growth	1.50%	10.51%
Eye & Ear Care Revenue	142.94M	183.32M
Eye & Ear Care Revenue Growth	-22.03%	2.17%
Dermatologicals Revenue	125.93M	128.95M
Dermatologicals Revenue Growth	-2.34%	-0.12%
Oral Care Revenue	101.05M	95.03M
Oral Care Revenue Growth	6.34%	-1.32%
Other OTC Revenue	15.39M	13.78M
Other OTC Revenue Growth	11.67%	14.58%
Revenue (Total)	1.09B	1.14B
Revenue (Total) Growth	-4.31%	1.10%

Gross Profit

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Gross Margin	500.88M	531.14M
North American OTC Healthcare Gross Margin Growth	-5.70%	0.42%
International OTC Healthcare Gross Margin	94.70M	103.32M
International OTC Healthcare Gross Margin Growth	-8.35%	8.14%
Gross Profit (Total)	595.58M	634.46M
Gross Profit (Total) Growth	-6.13%	1.60%

Adjusted Gross Profit

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
North American OTC Healthcare Contribution Margin	380.03M	401.71M
North American OTC Healthcare Contribution Margin Growth	-5.40%	1.08%
International OTC Healthcare Contribution Margin	66.77M	77.03M
International OTC Healthcare Contribution Margin Growth	-13.33%	4.48%
Gross Profit (Other)	148.78M	155.72M
Gross Profit (Total)	595.58M	634.46M
Gross Profit (Total) Growth	-6.13%	1.60%

Data Source: Fiscal.ai Last updated: May 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error